| An ethical framework for global vaccine allocation EJ Emanuel, G Persad, A Kern, A Buchanan, C Fabre, D Halliday, J Heath, ... Science 369 (6509), 1309-1312, 2020 | 370 | 2020 |
| The obligation to participate in biomedical research GO Schaefer, EJ Emanuel, A Wertheimer JAMA: the journal of the American Medical Association 302 (1), 67-72, 2009 | 179 | 2009 |
| The Ethics of Producing In Vitro Meat GO Schaefer, J Savulescu Journal of applied philosophy 31 (2), 188-202, 2014 | 142 | 2014 |
| An ethics framework for big data in health and research V Xafis, GO Schaefer, MK Labude, I Brassington, A Ballantyne, HY Lim, ... Asian Bioethics Review 11 (3), 227-254, 2019 | 118 | 2019 |
| Autonomy and enhancement GO Schaefer, G Kahane, J Savulescu Neuroethics 7, 123-136, 2014 | 115 | 2014 |
| The perfect moral storm: diverse ethical considerations in the COVID-19 pandemic V Xafis, GO Schaefer, MK Labude, Y Zhu, LY Hsu Asian Bioethics Review 12, 65-83, 2020 | 81 | 2020 |
| Consent and the ethical duty to participate in health data research A Ballantyne, GO Schaefer Journal of medical ethics 44 (6), 392-396, 2018 | 79 | 2018 |
| The right to withdraw from research. GO Schaefer, A Wertheimer Kennedy Institute of Ethics Journal 20 (4), 329, 2010 | 57 | 2010 |
| Direct vs. indirect moral enhancement GO Schaefer Kennedy Institute of Ethics Journal 25 (3), 261-289, 2015 | 55 | 2015 |
| COVID-19 vaccine development: time to consider SARS-CoV-2 challenge studies? GO Schaefer, CC Tam, J Savulescu, TC Voo Vaccine 38 (33), 5085-5088, 2020 | 51 | 2020 |
| Enhancing the WHO’s proposed framework for distributing COVID-19 vaccines among countries EJ Emanuel, F Luna, GO Schaefer, KC Tan, J Wolff American journal of public health 111 (3), 371-373, 2021 | 42 | 2021 |
| Procedural moral enhancement GO Schaefer, J Savulescu Neuroethics 12, 73-84, 2019 | 42 | 2019 |
| Making vaccines available to other countries before offering domestic booster vaccinations GO Schaefer, RJ Leland, EJ Emanuel JAMA 326 (10), 903-904, 2021 | 40 | 2021 |
| What are the obligations of pharmaceutical companies in a global health emergency? EJ Emanuel, A Buchanan, SY Chan, C Fabre, D Halliday, J Heath, ... The Lancet 398 (10304), 1015-1020, 2021 | 40 | 2021 |
| Governing the access to COVID-19 tools accelerator: towards greater participation, transparency, and accountability S Moon, J Armstrong, B Hutler, R Upshur, R Katz, C Atuire, A Bhan, ... The Lancet 399 (10323), 487-494, 2022 | 39 | 2022 |
| The Right to Know: A Revised Standard for Reporting Incidental Findings GO Schaefer, J Savulescu Hastings Center Report 48 (2), 22-32, 2018 | 28 | 2018 |
| Precision medicine and big data: The application of an ethics framework for big data in health and research GO Schaefer, ES Tai, S Sun Asian Bioethics Review 11, 275-288, 2019 | 26 | 2019 |
| “Who is watching the watchdog?”: ethical perspectives of sharing health-related data for precision medicine in Singapore T Lysaght, A Ballantyne, V Xafis, S Ong, GO Schaefer, JMT Ling, ... BMC Medical Ethics 21, 1-11, 2020 | 23 | 2020 |
| On the ethics of vaccine nationalism: the case for the fair priority for residents framework EJ Emanuel, A Buchanan, SY Chan, C Fabre, D Halliday, RJ Leland, ... Ethics & international affairs 35 (4), 543-562, 2021 | 22 | 2021 |
| Genetic affinity and the right to ‘three-parent IVF’ GO Schaefer, MK Labude Journal of assisted reproduction and genetics 34, 1577-1580, 2017 | 20 | 2017 |
